Scarica l'app Stockscreener
13.77
2.76%
0.37
Dopo l'orario di chiusura:
13.77
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$13.40
Aprire:
$13.4
Volume 24 ore:
1.55M
Relative Volume:
1.17
Capitalizzazione di mercato:
$1.34B
Reddito:
$47.56M
Utile/perdita netta:
$-156.83M
Rapporto P/E:
-7.5246
EPS:
-1.83
Flusso di cassa netto:
$-127.98M
1 W Prestazione:
+24.05%
1M Prestazione:
+43.29%
6M Prestazione:
+53.17%
1 anno Prestazione:
-15.21%
Intervallo 1D:
$13.29
$13.94
Intervallo di 1 settimana:
$11.62
$14.23
Portata 52W:
$6.38
$16.66
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
13.77 | 1.24B | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
152.44 | 66.04B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.77 | 45.57B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.69 | 42.50B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.21 | 18.84B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
309.72 | 13.59B | 2.99B | 1.21B | 1.13B | 25.06 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-18 | Ripresa | H.C. Wainwright | Buy |
| 2025-02-11 | Iniziato | Deutsche Bank | Buy |
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Avadel Pharmaceuticals (NASDAQ:AVDL) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Avadel (AVDL) Q2 Revenue Jumps 64% - AOL.com
Avadel Pharmaceuticals Plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Wall Street Analysts Predict a 37.25% Upside in Avadel (AVDL): Here's What You Should Know - Yahoo Finance
Avadel Pharmaceuticals Plc (NASDAQ:AVDL) Has Found A Path To Profitability - 富途牛牛
Results: Avadel Pharmaceuticals plc Exceeded Expectations And The Consensus Has Updated Its Estimates - simplywall.st
Avadel Pharmaceuticals plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - Yahoo Finance
Craig-Hallum Maintains Buy Rating for Avadel Pharmaceuticals with $18 Price Target - AInvest
Avadel Pharmaceuticals Q2 2025 Earnings Call Transcript: Forward-Looking Statements and Risks - AInvest
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q2 2025 Earnings Call Transcript - Insider Monkey
Avadel raises 2025 revenue guidance to $275M as LUMRYZ patient base grows 63% year-over-year - MSN
Avadel Pharmaceuticals shares fall 2.43% intraday after announcing inducement awards. - AInvest
Avadel Pharmaceuticals stock price target raised to $24 at H.C. Wainwright - Investing.com Nigeria
Avadel Pharmaceuticals: HC Wainwright Raises Buy Rating, PT to $24 - AInvest
Avadel Pharmaceuticals PLC (AVDL) Q2 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada
Avadel Pharmaceuticals Raises 2025 Revenue Guidance to $275M Amid 63% YoY Growth in LUMRYZ Patient Base - AInvest
Avadel Pharmaceuticals Reports Strong Q2 Growth - TipRanks
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel: Q2 Earnings Snapshot - The Washington Post
Avadel Pharmaceuticals PLC reports results for the quarter ended June 30Earnings Summary - TradingView
AVADEL PHARMACEUTICALS PLC SEC 10-Q Report - TradingView
Avadel Pharma earnings beat by $0.07, revenue topped estimates - Investing.com Nigeria
Avadel Pharma Q2 revenue up 64%, raises 2025 guidance - MarketScreener
Earnings Flash (AVDL) Avadel Pharmaceuticals Posts Q2 EPS $0.10, vs. FactSet Est of $0.03 - MarketScreener
Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results - TradingView
Avadel raises FY25 revenue guidance to $265-$275 mln after Q2 net rev. of $68.1 mln. - AInvest
Avadel Q2 rev up 64% to $68.1mln, raises FY25 guidance to $265-$275mln. - AInvest
Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance - The Manila Times
Avadel Earnings: Revenue Soars 64%, Reports First Profit Since LUMRYZ Launch, Boosts 2025 Outlook - Stock Titan
Avadel Pharmaceuticals plc Volume Confirms Breakout — Analysts BullishSwing Trading Plan With Smart Signals in Review - beatles.ru
What catalysts could drive Avadel Pharmaceuticals plc stock higher in 2025Discover undervalued opportunities early - Jammu Links News
What is the risk reward ratio of investing in Avadel Pharmaceuticals plc stockUnlock powerful trading tools for investors - Jammu Links News
What is the dividend policy of Avadel Pharmaceuticals plc stockSuperior investment outcomes - Jammu Links News
What analysts say about Avadel Pharmaceuticals plc stockUnprecedented growth rates - Jammu Links News
What is Avadel Pharmaceuticals plc company’s growth strategyBoost your returns with professional guidance - Jammu Links News
How many analysts rate Avadel Pharmaceuticals plc as a “Buy”Superior profit margins - Jammu Links News
How does Avadel Pharmaceuticals plc compare to its industry peersHigh-yield capital appreciation - Jammu Links News
Is Avadel Pharmaceuticals plc a good long term investmentFree Predictions - Jammu Links News
When is Avadel Pharmaceuticals plc stock expected to show significant growthOutperformance with explosive growth - Jammu Links News
How volatile is Avadel Pharmaceuticals plc stock compared to the marketCapitalize on emerging growth stocks - Jammu Links News
What are the latest earnings results for Avadel Pharmaceuticals plcInvest in stocks with strong fundamentals - Jammu Links News
A Piece Of The Puzzle Missing From Avadel Pharmaceuticals plc's (NASDAQ:AVDL) 26% Share Price Climb - simplywall.st
What are Avadel Pharmaceuticals plc company’s key revenue driversExpert Picks Updates Backed By Experts - Jammu Links News
What institutional investors are buying Avadel Pharmaceuticals plc stockBeginner Investor Signals For Every Investor - jammulinksnews.com
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7 - The Manila Times
How Avadel Pharmaceuticals plc stock performs during market volatilityEntry Alert Based on Volume Spikes Detected - beatles.ru
Visualizing Avadel Pharmaceuticals plc stock with heatmapsCommunity Strategy With High Win Rate Backtested - metal.it
What makes Avadel Pharmaceuticals plc stock attractive to long term investorsFree Swing Trading Entry Point Signals - Newser
Can Avadel Pharmaceuticals plc recover in the next quarterAI Trading Suggestions With Accuracy Focus Released - metal.it
What MACD signals say about Avadel Pharmaceuticals plcEarly Entry Planner for Swing Candidates - Newser
What makes Avadel Pharmaceuticals plc stock price move sharplyEquity Market Return Forecast Model Update - Newser
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.37%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):